Related Experiment Video

Updated: Jun 21, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

[Heavy-hearted: chronic constrictive pericarditis]

P Paule1, L Navarro, G Chiche

  • 1Service de Cardiologie, Hôpital d'Instruction des Armées A. Laveran, 13998 Marseille Armées, France. philippe.paule@orange.fr

Medecine Tropicale : Revue Du Corps De Sante Colonial
|July 31, 2009
PubMed

Insights

This case report details a Moroccan woman diagnosed with chronic constrictive pericarditis, highlighting the role of imaging in diagnosis. Treatment involved pericardectomy and antituberculosis drugs, especially relevant in developing countries.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Medical Case Reports

Background:

  • Constrictive pericarditis is a cardiac condition often caused by tuberculosis, particularly in developing nations.
  • Early and accurate diagnosis is crucial for effective management and improved patient outcomes.

Observation:

  • A 62-year-old Moroccan woman presented with generalized edema, prompting hospitalization.
  • Diagnostic workup revealed pericardial calcification and characteristic hemodynamic findings consistent with constrictive pericarditis.

Findings:

  • Cardiac MRI proved valuable for detailed anatomical and physiological assessment in this complex case.
  • Tuberculosis was considered a likely contributing factor, given the patient's origin and the condition's prevalence in developing countries.

Implications:

  • This case underscores the importance of considering tuberculosis in constrictive pericarditis, especially in endemic regions.
  • Advanced imaging modalities like cardiac MRI enhance diagnostic accuracy for challenging pericardial diseases.
  • Combined surgical (pericardectomy) and medical (antituberculosis therapy) management is essential for favorable prognoses.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Concept Videos

Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...